This is the mail archive of the ecos-bugs@sources.redhat.com mailing list for the eCos project.


Index Nav: [Date Index] [Subject Index] [Author Index] [Thread Index]
Message Nav: [Date Prev] [Date Next] [Thread Prev] [Thread Next]
Other format: [Raw text]

This one looks hot. News incredible, read it now before the morn


*****st0k alert*****st0k ALERT******st0K ALERT******st0K ALERT*******

ISSUED: FOR JULY 27, 2005    SYMBOL::PSiV   

News was released after the market close today.  
Those members that took our advice over the weekend to keep a keen eye on PSiV today are obviously happy they did.  Up over 85%! Tomorrow we urge you to keep the watch.  Being news was released after the close, tomorrow could prove even more exciting than today.
 
Here's the News released just moments ago. Important news for PSiV..
Pacific Sunset Investments Signs Agreement With Advanomics -- Support and Lab Services
Monday July 25, 4:21 pm ET 
Go to yahoo or any financial site to read the news now!
 
BioTechnology News.....  Tomorrow watch again.. Radar Alert
Pacific Sunset Investments Inc.
 Symbol: PSiV
Current Price:  .45
 
How many times have you heard about this????
adverse drug reactions accounted for more than 2.2 million serious cases and over 100,000 deaths,  Given a choice, if possible, wouldn't you want a test to make sure you didn't suffer a deadly reaction to a prescribed drug first?
 
PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV
A study published in the Journal of the American Medical Association reported that adverse drug reactions accounted for more than 2.2 million serious cases and over 100,000 deaths, making adverse drug reactions (ADRs) one of the leading causes of hospitalization and death in the United States. 
 
Breaking News for Pacific Sunset Investments
 
Pacific Sunset Investments Completes Gen ID Acquisition
HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--May 20, 2005--Pacific Sunset Investments, Inc. ("Pacific Sunset") (OTC:PSiV announced that it has completed its acquisition of Gen-ID Lab Services, LLC, a California limited liability corporation specializing in Single Nucleotide Polymorphism analysis data. In addition, the board of directors of Pacific Sunset has appointed Douglas Freedman to its board of directors with experience in marketing. Additionally, the company has appointed Dr. Steve N. Slilaty, Ph.D., to head an Advisory Board to assist the company with reviewing new alternatives in the "SNP" field of technology. 
 
Gen ID will provide "SNP" (Single Nucleotide Polymorphism) analysis data. The results of SNP analysis provide physicians with a more enlightened choice of drugs and they will also be able to predict the effectiveness of the drugs for individual patients. The use of an SNP test to help treat childhood leukemia is currently being used by doctors and hospitals in the United States. 
 
(This is a partial clip of the news.  We suggest you go read the whole release.  Our opinion is, this is important technology.  Go to yahoo or any financial site and read the news)
 
CONCLUSION:
adverse drug reactions accounted for more than 2.2 million serious cases and over 100,000 deaths,  Doesn't this say it all? 
 
 A company to watch!
 
AGGRESSIVE INVESTORS TAKE NOTE NOW! 
PUT Pacific Sunset Investments Inc. PSiV
ON YOUR RADAR SCREENS NOW,
AND WATCH THIS COMPANY STARTING NOW
 

Disc:
Information within this email contains "forwardlooking statements" within 
the meaning of Section 27Aof the Securities Act of 1933 and Section 21B of 
the Securities Exchange Act of 1934. Any statements that express or involve 
discussions with respect to predictions, expectations, beliefs, 
plans, projections, objectives, goals, assumptions or future events or 
performance are not statements of historical fact and may be "forward 
looking statements". "Forward looking statements" are based on 
expectations, estimates and projections at the time the statements are made 
that involve a number of risks and uncertainties which could cause actual 
results or events to differ materially from those presently anticipated. 
Forward looking statements in this action may be identified through the use 
of words such as "projects", "foresee", "expects", "will", "anticipates", 
"estimates", "believes", "understands" or that by statements indicating 
certain actions "may", "could", or "might" occur. Risk factors include 
general economic and business conditions, the ability to acquire and develop 
specific projects, the ability to fund operations and changes in consumer 
and business consumption habits and other factors overwhich the company has 
little or no control. The publisher of this newsletter does not represent 
that the information contained in this message states all material facts or 
does not omit a material fact necessary to make the statements therein not 
misleading. All information provided within this email pertaining to 
investing, ST0CKs, securities must be understood as information provided and 
not investment advice. The publisher of this newsletter advises all readers 
and subscribers to seek advice from a registered professional securities 
representative before deciding to trade in ST0CKs featured within this 
email. None of the material within this report shall be construed as any 
kind of investment advice or solicitation. Many of these companies are on 
the verge of bankruptcy. You can lose all your money by investing in this 
ST0CK. We urge you to read the company's SEC filings now, before you invest. 
The publisher of this newsletter is not a registered invstment advisor. 
Subscribers should not view information herein as legal, tax, accounting or 
investment advice. In compliance with the SecuritiesAct of 1933, Section 
17(b), The publisher of this newsletter is contracted to receive two hundred  
thousand free trading shares from a third party, not an officer, director or 
affiliate shareholder for the circulation of this report. Be aware of an 
inherent conflict of interest resulting from such compensation due to the 
fact that this is a paid advertisement and is not without bias. The party 
that paid us has a position in the ST0CK they will sell at anytime without 
notice. This could have a negative impact on the price of the ST0CK, causing 
you to lose money. All factual information in this report was gathered from 
public sources, including but not limited to SEC filings, Company Websites 
and Company Press Releases. The publisher of this newsletter believes this 
information to be reliable but can make no guarantee as to its accuracy or 
completeness. Use of the material within this email constitutes your 
acceptance of these terms. 


Index Nav: [Date Index] [Subject Index] [Author Index] [Thread Index]
Message Nav: [Date Prev] [Date Next] [Thread Prev] [Thread Next]